You can find the annual or quarterly income statement of ImageneBio Ord Shs here for insights into the performance and operational efficiency of ImageneBio Ord Shs.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q4

FY2025Q3

Total revenue

--0.00

Revenue

--0.00

Operating expenses

--8.50M

--26.59M

R&D expenses

--3.27M

--15.56M

Depreciation, depletion, and amortization

--393.00K

----

Other operating expenses

--49.25M

----

Operating profit

---8.50M

---26.59M

Net non-operating interest income (expenses)

Other non-operating income (expenses)

---1.12M

--1.84M

Income before tax

---7.18M

---24.85M

Income tax

---276.00K

---74.00K

Income after tax

---6.91M

---24.78M

Net income from continuous operations

---6.91M

---24.78M

Net income attributable to controlling interests

---6.91M

---25.63M

Net income attributable to common shareholders

---6.91M

---25.63M

Basic earnings per share

---0.86

---3.01

Diluted earnings per share

---0.86

---3.01

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

